T Heise, TR Pieber - Diabetes Obes Metab, 2007 - journals.pcommed.com While the advantages of the two basal insulin analogues, glargine and detemir,
over neutral protamine Hagedorn are well established, the relative merit of the
two compared with each other has been a matter of some controversy. The two ... Cited by 46 - Related articles - View as HTML - All 4 versions
WT Cefalu - Clinical Pharmacology & Therapeutics, 2007 - nature.com Type 2 diabetes, the most common form of diabetes, is characterized by
abnormalities in hepatic glucose production, insulin resistance, and a
progressive decline in -cell function over time. To treat effectively the ... Cited by 14 - Related articles - All 4 versions
P Levy - Medscape General Medicine, 2007 - pubmedcentral.nih.gov Type 2 diabetes is a progressive disease that is reaching epidemic proportions.
Whereas most patients are initially managed with oral antidiabetic agents
(OADs), the majority eventually require insulin to maintain glycemic ... Cited by 12 - Related articles - All 5 versions
RW Grant, DJ Wexler, AJ Watson, WT Lester, … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—Respondents reported using a median of five major considerations
(interquartile range 4–6) at each stage. Frequently cited major considerations
included overall assessment of the patient's health/comorbidity, A1C level, ... Cited by 10 - Related articles - BL Direct - All 5 versions
- ►clinicaltherapeutics.com [PDF] LL Ilag, L Kerr, JK Malone, MH Tan - Clinical therapeutics, 2007 - Elsevier Methods: A systematic search of Ovid, MEDLINE, and EMBASE (1995–2007) was
performed to identify published randomized controlled trials comparing prandial
premixed insulin analogues with basal insulin analogues, with or without ... Cited by 9 - Related articles - All 4 versions
- ►nih.gov I Hartman - Clinical medicine & research, 2008 - Marshfield Clinic A growing body of medical research has demonstrated that intensive control of
serum glucose levels can minimize the development of diabetes-related
complications. Success with insulin management ultimately depends on how ... Cited by 10 - Related articles - All 8 versions
DC Robbins, PJ Beisswenger, A Ceriello, RB … - Clinical therapeutics, 2007 - Elsevier Background: In people without diabetes, 50% of daily insulin secretion is basal
and the remainder is postprandial. Hence, it would be expected that insulin
replacement therapy in a 50/50 ratio with each meal would mimic physiologic ... Cited by 9 - Related articles - All 3 versions
EJ Warm - Current Diabetes Reviews, 2007 - ingentaconnect.com Division of General Internal Medicine, University of Cincinnati College of
Medicine, USA Abstract: There is a significant gap between evidenced-based
diabetes care and actual care delivery. The Chronic Care Model (CCM) was ... Cited by 7 - Related articles - BL Direct - All 2 versions
IB Hirsch - JAMA, 2009 - Am Med Assoc Certainly, SSI has evolved considerably since first described by Joslin more
than 70 years ago. 4 For decades, insulin doses were based on the amount of
glycosuria (fractional urine glucose testing) for both inpatient and ... Cited by 6 - Related articles - All 2 versions
